Occult bloodstream infection syndromes
Jump to navigation
Jump to search
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Jason Le, B.S.[2]
Overview
Occult bloodstream infection (occult bacteremia) is the presence of viable bacteria in the blood of a well-appearing, non-toxic patient without a clinically apparent focus of infection at the initial evaluation, with the diagnosis established when a blood culture obtained during that encounter subsequently becomes positive.[1]
Clinical contexts
- The syndrome is most clinically relevant in two settings:
- Well-appearing febrile young children, historically 3–36 months of age: occult bacteremia was formerly a major consideration in children with fever without a source (FWS).
- Adults discharged from acute-care settings: blood cultures may become positive after discharge in patients without an identified source or septic appearance, requiring systems for prompt recall and reassessment. Detailed adult diagnostic and management pathways belong in dedicated adult microchapters.
- FWS refers to fever of short duration without an identified source after history and physical examination; it should not be conflated with fever of unknown origin, which represents a more prolonged diagnostic syndrome.[2]
Modern epidemiology and clinical significance
- The epidemiology of occult bacteremia in well-appearing children has changed substantially following routine conjugate vaccination against Haemophilus influenzae type b and Streptococcus pneumoniae.
- Before routine conjugate vaccination, occult bacteremia occurred in approximately 3–12% of well-appearing children with FWS and temperature ≥39°C. After Hib vaccination the rate decreased to approximately 1.9%, and after introduction of pneumococcal conjugate vaccination it declined to approximately 0.25–0.5%.[1]
- After pneumococcal conjugate vaccination, the pathogen distribution shifted away from predominantly pneumococcal and Hib bacteremia toward organisms including Escherichia coli, Salmonella spp., and Staphylococcus aureus. In one large US cohort, pneumococcal bacteremia decreased by 95.3% after PCV13; E. coli, Salmonella spp., and S. aureus then accounted for 77% of bacteremia, and 76% of bacteremic episodes occurred with an identifiable source (34% urinary tract infection, with 93% of E. coli bacteremia being urinary-source).[3]
- The marked reduction in prevalence has changed the clinical problem from routine screening for occult bacteremia to risk-stratified evaluation for invasive bacterial infection.[1][4]
Current clinical approach
- In a well-appearing, fully vaccinated child aged 3–36 months with FWS, routine CBC and blood-culture screening with empiric antibiotics is no longer recommended solely because of fever; evaluation should instead focus on currently more prevalent serious bacterial infections, particularly urinary tract infection and occult pneumonia.[1][4]
- Urinary tract infection is now the leading occult serious bacterial infection in this age group — E. coli UTI is the most common serious bacterial infection in febrile children younger than 24 months, with a prevalence of approximately 5–7% — whereas occult bacteremia has become an uncommon outcome in fully vaccinated, well-appearing children.[4]
- Because post-PCV13 bacteremia in this age group usually occurs with an identifiable source, a focused examination and targeted studies should accompany any blood culture obtained, rather than isolated culture collection.[3]
- Vaccination and immune status are key risk modifiers. Children who are under- or incompletely vaccinated against Hib or pneumococcus, particularly those with fewer than 2 doses of each vaccine, and children with immunodeficiency warrant broader consideration of occult bacteremia and invasive bacterial infection.[5]
- When invasive bacterial infection remains a concern, procalcitonin and CRP are more informative than WBC count alone, which has poor sensitivity for invasive bacterial infection.[6]
- In a systematic review and meta-analysis of young febrile infants (a population distinct from the 3–36-month group), a procalcitonin cutoff of 0.5 ng/mL was superior to CRP (20 mg/L) for detecting invasive bacterial infection, and the two biomarkers should not be assumed interchangeable where procalcitonin is available; detailed thresholds are addressed in the Laboratory findings microchapter.[7]
- The low prevalence of true bacteremia means that in well-appearing children without localizing signs, a positive blood culture is more likely to represent a contaminant than a true pathogen — contemporary pediatric series report that roughly 75–80% of positive cultures are contaminants or non-pathogens; pretest probability should therefore guide testing and interpretation.[8][9][10]
- Toxic appearance, hemodynamic instability, or other features of sepsis change the clinical pathway. These patients require evaluation and treatment for possible invasive infection rather than an occult-bacteremia risk-stratification approach.[4]
Key clinical distinctions
| Syndrome | Typical clinical context | Clinical implication |
|---|---|---|
| Occult bloodstream infection | Well-appearing patient; no apparent focus; blood culture subsequently positive | Requires interpretation in the context of pretest probability, source evaluation, contamination risk, and host risk factors |
| FWS | Short-duration fever without an identified source after history and examination | In young children, directs risk-stratified evaluation for serious bacterial infection; not synonymous with occult bacteremia |
| Overt sepsis/invasive infection | Toxic appearance, hemodynamic compromise, or other evidence of systemic illness | Requires immediate evaluation and empiric treatment as clinically indicated rather than conservative occult-bacteremia screening |
| FUO | Prolonged unexplained fever | Represents a different diagnostic syndrome and should not be conflated with FWS |
High-yield clinical points
- The modern vaccine era has made occult bacteremia uncommon among fully vaccinated, well-appearing children with FWS.
- The principal occult bacterial target in this population is now urinary tract infection, not routine blood-stream screening.
- Do not apply pre-conjugate-vaccine algorithms based on reflexive CBC, blood culture, and empiric ceftriaxone to every well-appearing, fully vaccinated child with FWS.
- Do not use WBC count alone to rule in or rule out invasive bacterial infection.
- Check immunization status and immune status before deciding that occult bacteremia is a low-risk diagnosis.
- Interpret a positive blood culture in the context of contamination risk, organism identity, and the patient's clinical probability of true bacteremia.
Evidence limitations and areas of uncertainty
- The precise incremental risk of occult bacteremia in incompletely vaccinated children in the current era remains uncertain because contemporary vaccine coverage, herd immunity, and age-specific immune factors have altered the baseline risk.[1]
- The optimal biomarker thresholds and the degree to which procalcitonin and CRP can substitute for one another remain areas of ongoing evidence refinement.[7]
- Prospective evaluation of fever-without-source pathways has demonstrated incomplete adherence to some guidelines without a clear increase in missed severe infection, suggesting that the intensity of some diagnostic algorithms may exceed what is necessary in selected low-risk populations.[11]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Jana L. Anderson, Fernanda Bellolio. Fever without a Source 3–36 Months. Evidence-Based Emergency Care. 2023.
- ↑ Lacroix L, Papis S, Mardegan C; et al. (2023). "Host biomarkers and combinatorial scores for the detection of serious and invasive bacterial infection in pediatric patients with fever without source". PLOS ONE. 18 (11): e0294032. doi:10.1371/journal.pone.0294032.
- ↑ 3.0 3.1 Greenhow TL, Hung YY, Herz A. (2017). "Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines". Pediatrics. 139 (4): e20162098. doi:10.1542/peds.2016-2098.
- ↑ 4.0 4.1 4.2 4.3 Cooper ML, Iyer RS, Chan SS; et al. (2025). "ACR Appropriateness Criteria® Fever Without Source or Unknown Origin-Child: 2024 Update". Journal of the American College of Radiology. 22 (5S): S243–S260. doi:10.1016/j.jacr.2025.02.029.
- ↑ Cioffredi LA, Jhaveri R. (2016). "Evaluation and Management of Febrile Children: A Review". JAMA Pediatrics. 170 (8): 794–800. doi:10.1001/jamapediatrics.2016.0596.
- ↑ Hamilton JL, Evans SG, Bakshi M. (2020). "Management of Fever in Infants and Young Children". American Family Physician. 101 (12): 721–729. PMID 32538597 Check
|pmid=value (help). - ↑ 7.0 7.1 Norman-Bruce H, Umana E, Mills C; et al. (2024). "Diagnostic Test Accuracy of Procalcitonin and C-Reactive Protein for Predicting Invasive and Serious Bacterial Infections in Young Febrile Infants: A Systematic Review and Meta-Analysis". The Lancet Child & Adolescent Health. 8 (5): 358–368. doi:10.1016/S2352-4642(24)00021-X. PMID 38499017 Check
|pmid=value (help). - ↑ Sard B, Bailey MC, Vinci R. (2006). "An Analysis of Pediatric Blood Cultures in the Postpneumococcal Conjugate Vaccine Era in a Community Hospital Emergency Department". Pediatric Emergency Care. 22 (5): 295–300. doi:10.1097/01.pec.0000215137.51909.16. PMID 16714955.
- ↑ Mannino Avila E, Stucky Fisher E, Rhee K. (2021). "True Versus False Bacteremia in Infants and Children Less Than 3 Years of Age". Pediatric Emergency Care. 37 (6): e307–e312. doi:10.1097/PEC.0000000000001585. PMID 30106869.
- ↑ Theodosiou AA, Mashumba F, Flatt A. (2019). "Excluding Clinically Significant Bacteremia by 24 Hours in Otherwise Well Febrile Children Younger Than 16 Years: A Study of More Than 50,000 Blood Cultures". The Pediatric Infectious Disease Journal. 38 (9): e203–e208. doi:10.1097/INF.0000000000002359. PMID 31261363.
- ↑ Keuning MW, Klarenbeek NN, Bout HJ; et al. (2024). "Prospective multicenter evaluation of adherence to the Dutch guideline for children aged 0–16 years with fever without a source—febrile illness in children (FINCH) study". European Journal of Pediatrics. 183 (7): 2921–2933. doi:10.1007/s00431-024-05553-z.